PRI-MED SYMPOSIA Pri-Med New York CONFERENCE & EXHIBITION October 3-5, 2008 New York, NY Earn up to 17 AMA PRA Category 1 Credit(s)
Pre-Conference Symposia Day Schedule Track 1 Thursday, October 2, 2008 6:30 AM 7:30 AM Registration & Breakfast 7:30 AM 7:45 AM Opening Remarks 7:45 AM 9:00 AM Overactive Bladder: Improving Outcomes, Preserving Quality of Life 9:15 AM 10:30 AM Strategies in Treating CV Risk: A Focus on Hyperglycemia and Dyslipidemia 10:45 AM 12:00 PM Implementing and Monitoring Treatment in Chronic Pain: Improving Symptoms and Quality of Life 12:30 PM 1:45 PM Evidence Based Clinical Management of Dementia with Comorbid Depression 2:00 PM 3:15 PM Managing Triglycerides: A Crucial Component of Cardiovascular Risk Reduction 3:30 PM 4:45 PM What Every Practitioner Should Know About Incretin Hormones: Evolving Treatment Strategies for Type 2 Diabetes *Titles are subject to change PRE-CONFERENCE SYMPOSIA DAY ACCREDITATION STATEMENT Pri-Med institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. DESIGNATION STATEMENT Pri-Med designates this educational activity for a maximum of 7.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. AAFP APPLICATION Application for CME credit has been filed with the American Academy of family Physicians. Determination of credit is pending. AANP ACCREDITATION Pri-Med institute is approved as a provider of nurse practitioner continuing education by the American Academy of nurse Practitioners. AANP provider 040308. This program has been approved for 7.5 contact hours of continuing education (which includes 3.75 hours of pharmacology). AMERICAN WITH DISABILATIES STATEMENT In accordance with the Americans with Disabilities Act, Pri-Med institute seeks to make this conference accessible to all. if you have a need which might require special accommodations, please call 877-4PRI-MED or email support@pri-med.com three weeks prior to the meeting. COMMERCIAL SUPPORT This CME activity is supported by educational grants from Allergan, Inc, Abbott Laboratories, Forest Pharmaceuticals, Inc., GlaxoSmithKline, Daiichi Sankyo, Inc and Merck & Co. INDUSTRY-SUPPORTED SYMPOSIA ACCREDITATION Symposia are produced independently of Harvard Medical School and Columbia University Medical Center of New York Presbyterian Hospital. Sessions are planned and produced in accordance with the Accreditation Council for Continuing Medical Education. To obtain credit for industry-supported Symposia, you will need to scan your Attendance ScanCard at each symposium attended. Credit certificates will either be distributed at the conclusion of the symposium or mailed to you by the accrediting institution approximately eight weeks after the close of the conference.
Pre-Conference Symposia Day Schedule Track 2 Thursday, October 2, 2008 6:30 AM 7:30 AM Registration & Breakfast 7:30 AM 7:45 AM Opening Remarks 7:45 AM 9:00 AM Optimal Management of Asthma: Use the Right Tools 9:15 AM 10:30 AM Key Concepts for Unlocking the Door to Detection and Management of Genital Herpes 10:45 AM 12:00 PM Taking the Headache Out of Migraine Diagnosis and Management 12:30 PM 1:45 PM The Moving LDL Target: Getting Your Patients to Goal 2:00 PM 3:15 PM Optimizing Hypertension Treatment: Strategies for Success During the breaks for 15 min Asthma Inhaler Workshop *Titles are subject to change PRE-CONFERENCE SYMPOSIA DAY ACCREDITATION STATEMENT Pri-Med institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. DESIGNATION STATEMENT Pri-Med designates this educational activity for a maximum of 7.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. AAFP APPLICATION Application for CME credit has been filed with the American Academy of family Physicians. Determination of credit is pending. AANP ACCREDITATION Pri-Med institute is approved as a provider of nurse practitioner continuing education by the American Academy of nurse Practitioners. AANP provider 040308. This program has been approved for 7.5 contact hours of continuing education (which includes 3.75 hours of pharmacology). AMERICAN WITH DISABILATIES STATEMENT In accordance with the Americans with Disabilities Act, Pri-Med institute seeks to make this conference accessible to all. if you have a need which might require special accommodations, please call 877-4PRI-MED or email support@pri-med.com three weeks prior to the meeting. COMMERCIAL SUPPORT This CME activity is supported by educational grants from Merck & Co., Inc., Merck/Schering-Plough Pharmaceuticals, Daiichi Sankyo, Inc., GlaxoSmithKline. INDUSTRY-SUPPORTED SYMPOSIA ACCREDITATION Symposia are produced independently of Harvard Medical School and Columbia University Medical Center of New York Presbyterian Hospital. Sessions are planned and produced in accordance with the Accreditation Council for Continuing Medical Education To obtain credit for industry-supported Symposia, you will need to scan your Attendance ScanCard at each symposium attended. Credit certificates will either be distributed at the conclusion of the symposium or mailed to you by the accrediting institution approximately eight weeks after the close of the conference.
Breakfast Symposia Friday, October 3, 2008 6:15 AM -7:45 AM Essential Elements in the Management of Acute Respiratory Illnesses Jonathan L Temte, MD,PhD Advisory Committee on Immunization Practices Associate Professor, Department of Family Medicine University of Wisconsin School of Medicine and Public Health, Madison, WI Thomas M. File, MD Professor of Internal Medicine, College of Medicine Master Teacher, Head, Infectious Disease Section Northeastern Ohio Universities, Rootstown, OH Chief, Infectious Disease Section Director, HIV Research Summa Health System, Akron, OH Michael L Tapper, MD Clinical Professor of Medicine New York University School of Medicine, New York, NY Hospital Epidemiologist Director, Division of Infectious Diseases Lenox Hill Hospital, New York, NY Describe the impact of rapid diagnostic testing on appropriate use of antibiotics to treat acute respiratory illness Recognize complications of untreated viral respiratory infections and discuss their impact on morbidity/mortality Discuss the value of antiviral pharmacotherapy and periexposure prophylaxis for the prevention of acute complications of influenza and influenza-like illnesses Design and implement strategies to meet the need for immunization programs targeting vaccinepreventable acute respiratory infections Accreditation/Designation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Kentucky College of Medicine and HealthmattersCME. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits (TM). Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field. All faculty members participating in continuing medical education programs sponsored by the University of Kentucky Colleges of Pharmacy and Medicine Continuing Education Office are expected to disclose any real or perceived conflict of interest related to the content of their presentations. Copies of faculty disclosures will be given prior to the activity. University of Kentucky is an Equal Opportunity University. Commercial Support: This program is supported by an independent educational grant from Gilead Sciences Medical Affairs.
Lunch Symposium Friday, October 3, 2008 12:00 PM 1:30 PM A Practical Guide to Post Acute Coronary Syndrome Antithrombotic Therapy* James A. de Lemos, MD Associate Professor of Medicine University of Texas Southwestern Medical School Dallas, TX Amit Khera, MD,MSc,FACC Assistant Professor, Internal Medicine: Cardiology Division of Cardiology Director, Program in Preventive Cardiology University of Texas Southwestern Medical School Dallas, TX Outline key elements of the 2007 Updated ACC/AHA Guidelines for the Management of STEMI and UA/NSTEMI relating to long term management of the post ACS patient to prevent secondary events and reduce morbidity and mortality. Identify 3 adherence strategies that improve the role of dual antiplatelet therapy in preventing myocardial infarction and death in patients after stenting. Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Nursing Accreditation: Pri-Med Institute is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners, AANP provider 040308. This program has been approved for 1.5 contact hours of continuing education (which includes 0.75 hour of pharmacology). Commercial Support: This activity is supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.
Lunch Symposium Friday, October 3, 2008 12:00 PM 1:30 PM Demystifying Fibromyalgia: A Primary Care Primer Ronald Rapoport Director, Osteoporosis and Research Center Staff Rheumatologist, Charlton Memorial Hospital Fall River, MA Bill McCarberg, MD,FABPM Founder, Chronic Pain Management Program Kaiser Permanente San Diego, CA Kurt Kroenke, MD Professor of Medicine/Director of Fellowship Training Programs and Research Scientist Regenstrief Institute, Indiana University School of Medicine Indianapolis, IN Explain the ACR classification criteria to confirm a FMS diagnosis, with emphasis on positive and negative implications of the criteria Defend or challenge current perceptions regarding etiology and pathophysiology of FMS List the components of musculoskeletal/neurologic examination that differentiate FMS from other sources of pain Summarize individual and combined therapies available to FMS patients, from cognitive or operant behavior modification techniques and physical therapy to pharmacotherapy Identify up to date data on novel pharmacotherapies being evaluated for use in FMS Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Duke University School of Medicine and Context Healthcare Group. Designation Statement: The Duke University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from the Forest Research Institute.
Dinner Symposium Friday, October 3, 2008 5:45 PM 7:45 PM VTE Prevention in 2008: Are You Ready to Make a Difference? * Franklin Michota, Jr,MD Associate Professor of Medicine The Cleveland Clinic Lerner College of Medicine The Cleveland Clinic Cleveland, OH Amir Jaffer, MD Chief, Service of Medicine University of Miami Hospital Hialeah, FL Division Chief, Hospital Medicine Department of Medicine University of Miami Miller School of Medicine Miami, FL Discuss the challenges and opportunities in the prevention of venous thromboembolism (VTE) in at-risk patients. Describe the Joint Commission on Accreditation of Healthcare Organizations/National Quality Forum National Consensus Standards for the prevention of VTE. Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Nursing Accreditation: Pri-Med Institute is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners, AANP provider 040308. This program has been approved for 2.0 contact hours of continuing education (which includes 1 hour of pharmacology). Commercial Support: This activity is supported by an educational grant from sanofi-aventis.
Dinner Symposium Friday, October 3, 2008 5:45 PM 7:45 PM CHRONIC OPIOID THERAPY: Understanding Risk While Maximizing Analgesia Bruce D. Nicholson, MD Clinical Associate Professor, Department of Anesthesia The Pennsylvania State University School of Medicine Milton S. Hershey Medical Center Hershey, PA Director, Division of Pain Management Lehigh Valley Hospital and Health Network Allentown, PA Assess the risk level of those chronic pain patients most likely to benefit from opioid therapy Identify appropriate opioid analgesic agents, based on safety and efficacy data and patient presentation Optimize analgesia through titration, rotation, and conversion Use appropriate documentation to support opioid prescribing Accreditation Statement: Professional Postgraduate Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Professional Postgraduate Services designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is conducted as a part of the National Initiative on Pain Control (NIPC ), sponsored by Professional Postgraduate Services, Secaucus, NJ. Commercial Support: This CME activity is supported by an educational grant from Endo Pharmaceuticals Inc.
Breakfast Symposium Saturday, October 4, 2008 6:15 AM 7:45 AM Achieving Blood Pressure Control--The Time Is Now * William J. Elliott, MD,PhD Professor of Preventive Medicine, Internal Medicine and Pharmacology Rush Medical College Rush University Rush University Medical Center Chicago, IL Domenic A. Sica, MD Professor of Medicine and Pharmacology Medical College of Virginia Chief, Division of Clinical Pharmacology and Hypertension Virginia Commonwealth University Richmond, VA Identify target blood pressure goals outlined in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, with special attention to special populations such as patients with diabetes mellitus, the elderly, patients with metabolic syndrome, African American, and Hispanic patients. Describe at least 2 roles for combination therapy regimens in the treatment of moderate and severe hypertension. Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Nursing Accreditation: Pri-Med Institute is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners, AANP provider 040308. This program has been approved for 1.5 contact hours of continuing education (which includes 0.75 hours of pharmacology). Commercial Support: This activity is supported by an educational grant from Squibb /Sanofi Pharmaceuticals Partnership.
Lunch Symposium Saturday, October 4, 2008 12:00 PM 1:30 PM Is MDD Over Diagnosed? What Every Primary Care Professional Needs to Know Martin A. Quan, MD Professor of Family Medicine Director, Office of Continuing Medical Education David Geffen School of Medicine at UCLA Los Angeles, CA Diagnose patients with depression, using screening questions and analyzing patient somatic symptoms. Manage the patient with depression from diagnosis, through treatment, to a goal of achieving and maintaining remission. Accreditation Statement: The California Academy of Family Physicians designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits. TM Physicians should only claim credit commensurate with the extent of their participation in the activity. Designation Statement: This activity is sponsored by the California Academy of Family Physicians. Commercial Support: This activity is supported by an educational grant from Wyeth Pharmaceuticals.
Dinner Symposium Saturday, October 4, 2008 5:45 PM 7:45 PM RAPID: Rheumatoid Arthritis: Primary care Initiative for improved Diagnosis and outcomes Joseph A. Markenson, MD Professor of Clinical Medicine Hospital for Special Surgery Cornell Medical College New York, NY David S Kountz, MD Associate Professor of Medicine University of Medicine and Dentistry of New Jersey Newark, NJ Have increased knowledge regarding: a The early aggressive nature of joint damage in RA b The optimal management of RA through early diagnosis and aggressive initiation of diseasemodifying antirhuematic drug (DMARD) therapy c The risks and benefits of the therapeutic management of RA, including the long-term benefit of early, aggressive treatment; the long-term risks of not starting early therapy; the health risks of therapy, such as infections and malignancies; and other adverse events related to RA and its treatment d The benefits of a collaborative team approach for the optimal management of the patient with RA Increase their planned frequency of use (as compared to their current frequency of use) of the following evidence-based provisional RA diagnosis and patient care strategies: a Use of a focused physical examination and functional assessment questions b Use of appropriate laboratory tests c Early referral to the rheumatologist when RA is suspected d RA patient monitoring strategies such as reviewing RA patient immunizations e Coordinating patient care with a relevant specialist to ensure the best quality care Increased confidence in their ability to accurately diagnose and monitor patients with RA Accreditation Statement: The Chatham Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: The Chatham Institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. It is the policy of The Chatham Institute to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All faculty, planners, and managers who affect the content of medical education activities sponsored by The Chatham Institute are required to disclose to the audience any real or apparent conflict of interest related to the activity. Faculty, planners, and managers not complying with the disclosure policy will not be permitted to participate in this activity. Participants will receive disclosure information in writing at the educational activity. Commercial Support: This program is supported by educational grants from Abbott Laboratories, Amgen Inc./ Wyeth Pharmaceuticals, Bristol-Myers Squibb, Centocor, Inc., Genentech and Biogen Idec.
Breakfast Symposium Sunday, October 5, 2008 6:15 AM 7:45 AM Do Ask, Do Tell: Successful Smoking Interventions Katherine E. Galluzzi, DO,CMD Professor and Chairperson Department of Geriatrics Philadelphia College of Osteopathic Medicine Philadelphia, PA Screen all patients for smoking status Design individualized cessation interventions for patients who smoke Commit to active follow-up with patients along the smoking cessation path Accreditation Statement: The California Academy of Family Physicians designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits. TM Physicians should only claim credit commensurate with the extent of their participation in the activity. Designation Statement: This activity is sponsored by the California Academy of Family Physicians. Commercial Support: This activity is supported by an educational grant from Pfizer.
Lunch Symposium Sunday, October 5, 2008 12:00 PM 1:30 PM Looking Beyond Oral Agents: What to Do When Oral Therapies No Longer Maintain Treatment Goals in Type 2 Diabetes * Silvio Inzucchi, MD Program Chairman Endocrinology Professor of Medicine Lippard Laboratory of Clinical Investigation 101 Yale University New Haven, CT Michael E. Cobble, MD Board Certified Clinical Lipidologist AAFP, ADA, AHA, NLA Private Practice Primary Care Salt Lake City, UT Director Canyons Medical Center Sandy, UT Ellie Strock, APRN,CDE Education Director, Adult Nurse Practitioner Director WHO Collaborating Center Director, International Programs Education International Diabetes Center Park Nicollet Institute Minneapolis, MN Communicate the appropriate glucose goals for A1C, fasting plasma glucose, and postprandial plasma glucose to patients to enhance their understanding and adherence to diabetes therapy. Outline a patient-driven treatment algorithm for insulin therapy to allow patients to safely titrate to achieve A1C goals. Discuss the role of incretin-based therapy in the management of type 2 diabetes patients who are not in adequate glycemic control on oral agents. Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Nursing Accreditation: Pri-Med Institute is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners, AANP provider 040308. This program has been approved for 1.5 contact hours of continuing education (which includes 0.75 hours of pharmacology). Commercial Support: This activity is supported by an educational grant from Novo Nordisk Inc.
Industry-Supported Symposia Held during mealtime breaks during the Conference & Exhibition Attendance at Symposia sessions is limited Tickets are required for admission Registration for industry-supported Symposia is limited to physicians, physician assistants, and nurse practitioners currently engaged in patient care. Session information is subject to change *American with Disabilities Statement: In accordance with the Americans with Disabilities Act, Pri-Med Institute seeks to make this conference accessible to all. If you have a need which might require special accommodations, please call 877-4PRI-MED or e-mail support@pri-med.com three weeks prior to the meeting. 2008 M C Communications LLC. All rights reserved. Pri-Med is a registered trademark and Knowledge that touches patients is a trademark of M/C Communications, LLC. All other trademarks are the property of their respective owners. WWW.PRI-MED.COM/NYC 1-877-4PRI-MED (1-877-477-4633)